Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Nonclassical Ligand-Independent Regulation of Go Protein by an Orphan Class C G-Protein-Coupled Receptor.

Hajj M, De Vita T, Vol C, Renassia C, Bologna JC, Brabet I, Cazade M, Pastore M, Blahos J, Labesse G, Pin JP, Prézeau L.

Mol Pharmacol. 2019 Aug;96(2):233-246. doi: 10.1124/mol.118.113019. Epub 2019 Jun 12.

PMID:
31189666
2.

Activity-dependent regulation of T-type calcium channels by submembrane calcium ions.

Cazade M, Bidaud I, Lory P, Chemin J.

Elife. 2017 Jan 21;6. pii: e22331. doi: 10.7554/eLife.22331.

3.

Peptidomimetic Targeting of Cavβ2 Overcomes Dysregulation of the L-Type Calcium Channel Density and Recovers Cardiac Function.

Rusconi F, Ceriotti P, Miragoli M, Carullo P, Salvarani N, Rocchetti M, Di Pasquale E, Rossi S, Tessari M, Caprari S, Cazade M, Kunderfranco P, Chemin J, Bang ML, Polticelli F, Zaza A, Faggian G, Condorelli G, Catalucci D.

Circulation. 2016 Aug 16;134(7):534-46. doi: 10.1161/CIRCULATIONAHA.116.021347. Epub 2016 Aug 2.

PMID:
27486162
4.

Modulation of T-type calcium channels by bioactive lipids.

Chemin J, Cazade M, Lory P.

Pflugers Arch. 2014 Apr;466(4):689-700. doi: 10.1007/s00424-014-1467-5. Epub 2014 Feb 16. Review.

PMID:
24531745
5.

5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone.

Cazade M, Bidaud I, Hansen PB, Lory P, Chemin J.

Pflugers Arch. 2014 Sep;466(9):1759-68. doi: 10.1007/s00424-013-1411-0. Epub 2013 Dec 11.

PMID:
24327205
6.

Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2.

Cazade M, Nuss CE, Bidaud I, Renger JJ, Uebele VN, Lory P, Chemin J.

Mol Pharmacol. 2014 Feb;85(2):218-25. doi: 10.1124/mol.113.089581. Epub 2013 Nov 8.

PMID:
24214826

Supplemental Content

Loading ...
Support Center